Therapeutics Pipeline

Qualigen has a diverse portfolio of proprietary oncology product candidates:
Program: Indication Development Pre-IND Phase 1 Phase 2
AS1411: Pancreatic
AS1411: Breast (Triple Negative)
AS1411: Glioblastoma (Brain)
AS1411-GNP: Pancreatic
AS1411-GNP/R: Radiation-All types
AS1411-GNP/I: Imaging-All types
STARS: All types
RAS-F: Pancreatic
RAS-F: Lung
RAS-F: Colorectal